Access the full text.
Sign up today, get DeepDyve free for 14 days.
Samir Patel, A. McGeer, R. Melano, G. Tyrrell, K. Green, D. Pillai, D. Low (2011)
Susceptibility of Streptococcus pneumoniae to Fluoroquinolones in CanadaAntimicrobial Agents and Chemotherapy, 55
S. Lo, K. Mellor, R. Cohen, A. Alonso, S. Belman, Narender Kumar, P. Hawkins, R. Gladstone, A. Gottberg, B. Veeraraghavan, K. Ravikumar, R. Kandasamy, Sir Pollard, S. Saha, G. Bigogo, M. Antonio, B. Kwambana-Adams, S. Mirza, S. Shakoor, I. Nisar, J. Cornick, D. Lehmann, R. Ford, B. Sigaúque, P. Turner, J. Moïsi, S. Obaro, R. Dagan, I. Diawara, A. Skoczyńska, Hui Wang, P. Carter, K. Klugman, G. Rodgers, R. Breiman, L. McGee, S. Bentley, C. Almagro, E. Varon, Abdullah Zh, A. Brooks, A. Corso, A. Davydov, A. Maguire, A. Kiran, Benild Moiane, B. Beall, Chun-jiang Zhao, D. Aanensen, D. Everett, D. Faccone, Ebenezer Foster-Nyarko, E. Bojang, E. Egorova, E. Voropaeva, E. Sampane-Donkor, E. Sadowy, G. Nagaraj, Hélio Mucavele, H. Belabbes, N. Elmdaghri, J. Verani, J. Keenan, J. Lees, Jyothish Bhai, K. Ndlangisa, K. Zerouali, Leon Bentley, L. Titov, L. Gouveia, M. Alaerts, M. Ip, M. Brandileone, Md Hasanuzzaman, M. Paragi, Michele Nurse-Lucas, M. Plessis, Mushal Ali, N. Croucher, N. Wolter, N. Givon‐Lavi, N. Porat, Özgen Eser, P. Ho, Patrick Akpaka, P. Gagetti, Peggy-Estelle Tientcheu, P. Law, Rachel Benisty, R. Mostowy, R. Malaker, Samanta Almeida, S. Doiphode, S. Madhi, Shamala Sekaran, Stuart Clarke, S. Srifuengfung, S. Nzenze, T. Kastrin, T. Ochoa, W. Hryniewicz, Y. Urban (2022)
Emergence of a multidrug-resistant and virulent Streptococcus pneumoniae lineage mediates serotype replacement after PCV13: an international whole-genome sequencing studyThe Lancet. Microbe, 3
G. Zhanel, L. Palatnick, K. Nichol, Tracy Bellyou, D. Low, D. Hoban (2003)
Antimicrobial Resistance in Respiratory Tract Streptococcus pneumoniae Isolates: Results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002Antimicrobial Agents and Chemotherapy, 47
G. Tyrrell, M. Lovgren, N. Chui, J. Minion, S. Garg, J. Kellner, T. Marrie (2009)
Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre- and post-seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000-2006.Vaccine, 27 27
D. Scheifele, S. Halperin, L. Pelletier, J. Talbot, M. Lovgren, W. Vaudry, T. Jadavji, B. Law, N. Macdonald, R. Gold, Elaine Wang, E. Mills, M. Lebel, P. Déry, Robert Morris (2001)
Reduced susceptibility to penicillin among pneumococci causing invasive infection in children - Canada, 1991 to 1998.The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses, 12 4
Laura Marks, Ryan Reddinger, A. Hakansson (2012)
High Levels of Genetic Recombination during Nasopharyngeal Carriage and Biofilm Formation in Streptococcus pneumoniaemBio, 3
D. Greenberg, D. Speert, E. Mahenthiralingam, D. Henry, M. Campbell, D. Scheifele, the Network (2002)
Emergence of Penicillin-Nonsusceptible Streptococcus pneumoniae Invasive Clones in CanadaJournal of Clinical Microbiology, 40
L. McGee, L. McDougal, J. Zhou, B. Spratt, F. Tenover, R. George, R. Hakenbeck, W. Hryniewicz, J. Lefévre, A. Tomasz, K. Klugman (2001)
Nomenclature of Major Antimicrobial-Resistant Clones of Streptococcus pneumoniae Defined by the Pneumococcal Molecular Epidemiology NetworkJournal of Clinical Microbiology, 39
M. Pfaller, Ronald Jones, G. Doern, K. Kugler, The Group (1998)
Bacterial Pathogens Isolated from Patients with Bloodstream Infection: Frequencies of Occurrence and Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)Antimicrobial Agents and Chemotherapy, 42
A. Mizrahi, J. Marvaud, B. Pilmis, J. Van, C. Couzigou, C. Bruel, N. Engrand, A. Monnier, T. Lambert (2019)
Emergence of Ceftriaxone Resistance during a Case of Pneumococcal Meningitis with Fatal EvolutionAntimicrobial Agents and Chemotherapy, 64
Hao-Yuan Lee, Tsu‐lan Wu, L. Su, Hsin-Chieh Li, R. Janapatla, Chyi-Liang Chen, C. Chiu (2017)
Invasive pneumococcal disease caused by ceftriaxone-resistant Streptococcus pneumoniae in Taiwan.Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 51 4
J. Karlowsky, H. Adam, A. Golden, M. Baxter, K. Nichol, I. Martin, W. Demczuk, M. Mulvey, M. Gilmour, D. Hoban, G. Zhanel (2018)
Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011-15.The Journal of antimicrobial chemotherapy, 73 suppl_7
A. Golden, H. Adam, M. Gilmour, M. Baxter, I. Martin, K. Nichol, W. Demczuk, D. Hoban, G. Zhanel (2015)
Assessment of multidrug resistance, clonality and virulence in non-PCV-13 Streptococcus pneumoniae serotypes in Canada, 2011-13.The Journal of antimicrobial chemotherapy, 70 7
D. Adam (2002)
Global antibiotic resistance in Streptococcus pneumoniae.The Journal of antimicrobial chemotherapy, 50 Suppl
Gierke (2021)
255
M. Kyaw, R. Lynfield, W. Schaffner, A. Craig, J. Hadler, A. Reingold, A. Thomas, L. Harrison, N. Bennett, M. Farley, R. Facklam, J. Jorgensen, J. Besser, E. Zell, A. Schuchat, C. Whitney (2006)
Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae.The New England journal of medicine, 354 14
M. Lovgren, J. Spika, J. Talbot (1998)
Invasive Streptococcus pneumoniae infections: serotype distribution and antimicrobial resistance in Canada, 1992-1995.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 158 3
E. Feil, John Smith, M. Enright, B. Spratt (2000)
Estimating recombinational parameters in Streptococcus pneumoniae from multilocus sequence typing data.Genetics, 154 4
A. Campa, L. Balsalobre, C. Ardanuy, A. Fenoll, E. Perez-trallero, J. Liñares (2004)
Fluoroquinolone Resistance in Penicillin-resistant Streptococcus pneumoniae Clones, SpainEmerging Infectious Diseases, 10
L. Jetté, F. Lamothe (1989)
Surveillance of invasive Streptococcus pneumoniae infection in Quebec, Canada, from 1984 to 1986: serotype distribution, antimicrobial susceptibility, and clinical characteristicsJournal of Clinical Microbiology, 27
H. Adam, J. Karlowsky, K. Nichol, M. Gilmour, D. Hoban, J. Embree, G. Zhanel (2012)
Baseline epidemiology of Streptococcus pneumoniae serotypes in Canada prior to the introduction of the 13-valent pneumococcal vaccine.Microbial drug resistance, 18 2
W. Demczuk, I. Martin, Averil Griffith, B. Lefebvre, A. McGeer, M. Lovgren, G. Tyrrell, S. Desai, L. Sherrard, H. Adam, M. Gilmour, G. Zhanel (2012)
Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010-2012.Canadian journal of microbiology, 59 12
L. Hicks, L. Harrison, B. Flannery, J. Hadler, W. Schaffner, A. Craig, D. Jackson, A. Thomas, B. Beall, R. Lynfield, A. Reingold, M. Farley, C. Whitney (2007)
Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.The Journal of infectious diseases, 196 9
A. Brueggemann, D. Griffiths, Emma Meats, T. Peto, D. Crook, B. Spratt (2003)
Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential.The Journal of infectious diseases, 187 9
Leah Ricketson, J. Bettinger, M. Sadarangani, S. Halperin, J. Kellner (2022)
Vaccine effectiveness of the 7-valent and 13-valent pneumococcal conjugate vaccines in Canada: An IMPACT study.Vaccine
Andrew Simor, Marie Louie, D. Low (1996)
Canadian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae. Canadian Bacterial Surveillance NetworkAntimicrobial Agents and Chemotherapy, 40
R. Hakenbeck (2014)
Discovery of β-lactam-resistant variants in diverse pneumococcal populationsGenome Medicine, 6
J. Bettinger, D. Scheifele, J. Kellner, S. Halperin, W. Vaudry, B. Law, G. Tyrrell (2010)
The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000-2007.Vaccine, 28 9
R. Davidson, R. Melano, K. Forward (2007)
Antimicrobial resistance among invasive isolates of Streptococcus pneumoniae collected across Canada.Diagnostic microbiology and infectious disease, 59 1
C. John (1994)
Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 18 2
Liset Olarte, S. Kaplan, W. Barson, J. Romero, P. Lin, T. Tan, J. Hoffman, J. Bradley, L. Givner, E. Mason, K. Hulten (2016)
Emergence of Multidrug-Resistant Pneumococcal Serotype 35B among Children in the United StatesJournal of Clinical Microbiology, 55
K. Poehling, T. Talbot, M. Griffin, A. Craig, C. Whitney, E. Zell, C. Lexau, A. Thomas, L. Harrison, A. Reingold, J. Hadler, M. Farley, B. Anderson, W. Schaffner (2006)
Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine.JAMA, 295 14
K. Klugman (2002)
The successful clone: the vector of dissemination of resistance in Streptococcus pneumoniae.The Journal of antimicrobial chemotherapy, 50 Suppl S2
K. Nichol, H. Adam, J. Karlowsky, G. Zhanel, D. Hoban (2008)
Increasing Genetic Relatedness of Ciprofloxacin-Resistant Streptococcus pneumoniae Isolated in Canada from 1997 to 2005Antimicrobial Agents and Chemotherapy, 52
J. Karlowsky, Mark Jones, Deborah Draghi, D. Sahm (2003)
Clinical Isolates of Streptococcus pneumoniae with Different Susceptibilities to Ceftriaxone and CefotaximeAntimicrobial Agents and Chemotherapy, 47
ObjectivesTo assess the antimicrobial susceptibility of 14 138 invasive Streptococcus pneumoniae isolates collected in Canada from 2011 to 2020.MethodsAntimicrobial susceptibility testing was performed using the CLSI M07 broth microdilution reference method. MICs were interpreted using 2022 CLSI M100 breakpoints.ResultsIn 2020, 90.1% and 98.6% of invasive pneumococci were penicillin-susceptible when MICs were interpreted using CLSI meningitis or oral and non-meningitis breakpoints, respectively; 96.9% (meningitis breakpoint) and 99.5% (non-meningitis breakpoint) of isolates were ceftriaxone-susceptible, and 99.9% were levofloxacin-susceptible. Numerically small, non-temporal, but statistically significant differences (P < 0.05) in the annual percentage of isolates susceptible to four of the 13 agents tested was observed across the 10-year study: chloramphenicol (4.4% difference), trimethoprim-sulfamethoxazole (3.9%), penicillin (non-meningitis breakpoint, 2.7%) and ceftriaxone (meningitis breakpoint, 2.7%; non-meningitis breakpoint, 1.2%). During the same period, annual differences in percent susceptible values for penicillin (meningitis and oral breakpoints) and all other agents did not achieve statistical significance. The percentage of isolates with an MDR phenotype (resistance to ≥3 antimicrobial classes) in 2011 and 2020 (8.5% and 9.4%) was not significantly different (P = 0.109), although there was a significant interim decrease observed between 2011 and 2015 (P < 0.001) followed by a significant increase between 2016 and 2020 (P < 0.001). Statistically significant associations were observed between resistance rates to most antimicrobial agents included in the MDR analysis (penicillin, clarithromycin, clindamycin, doxycycline, trimethoprim/sulfamethoxazole and chloramphenicol) and patient age, specimen source, geographic location in Canada or concurrent resistance to penicillin or clarithromycin, but not biological sex of patients. Given the large isolate collection studied, statistical significance did not necessarily imply clinical or public health significance in some analyses.ConclusionsInvasive pneumococcal isolates collected in Canada from 2011 to 2020 generally exhibited consistent in vitro susceptibility to commonly tested antimicrobial agents.
Journal of Antimicrobial Chemotherapy – Oxford University Press
Published: May 3, 2023
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.